Citius Pharmaceuticals, Inc.
-$31.69M- Market cap
- $16.13M
- Debt
- +-$6.11M
- Cash
- −$41.71M
Capital structure 161% equity / -61% debt · EV / EBITDA 0.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
CTXR · current priceP/S 179.27x
$0.59Latest market snapshot
Implied fair value · at FOSL's multiple
$0.0099.8% below market
0.00 CTXR revenue / share×0.30x FOSL P/S=$0.00
Market $0.59Implied $0.00
FOSL · current priceP/S 0.30x
$5.15Latest market snapshot
Implied fair value · at CTXR's multiple
$3,044.6659,019.6% above market
16.98 FOSL revenue / share×179.27x CTXR P/S=$3,044.66
Market $5.15Implied $3,044.66